Skip to main content
. 2019 May 27;42(10):1167–1177. doi: 10.1007/s40264-019-00836-z
In this population-based, multinational cohort study to evaluate the cardiovascular safety of prucalopride versus polyethylene glycol 3350 (PEG), use of a common protocol and definitions, as well as propensity score (PS) stratification and trimming, yielded comparable study cohorts in four of the five data sources.
Differences in reimbursement practices in Germany meant that these analytic methods could not achieve balance for key covariates within the German cohort.
Thus, only data from the UK and Sweden (i.e. four of five data sources) were eventually included in the pooled analyses.